Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imad Sheiban

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-ICarlos Macaya, Héctor M García-García, Antonio Colombo, et al.
American Heart Journal|May 22, 2012
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe Biondi-Zoccai, Marco Valgimigli, Massimo Margheri, et al.
International Journal of Cardiology|August 17, 2013
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patientsAlessandro Lupi, Andrea Rognoni, Gioel Gabrio Secco, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 24, 2013
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacementFabrizio D'Ascenzo, Flavia Ballocca, Claudio Moretti, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Journal of the American College of Cardiology|June 7, 2008
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) RegistryEmanuele Meliga, Hector Manuel Garcia-Garcia, Marco Valgimigli, et al.
The Journal of Invasive Cardiology|July 12, 2012
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stentsMichael S Lee, Kyung Woo Park, Si-Hyuck Kang, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 27, 2014
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methodsClaudio Moretti, Erika Cavallero, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology|August 26, 2011
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)Marco Valgimigli, Gianluca Campo, Stefania Gambetti, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-ICarlos Macaya, Héctor M García-García, Antonio Colombo, et al.
American Heart Journal|May 22, 2012
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe Biondi-Zoccai, Marco Valgimigli, Massimo Margheri, et al.
International Journal of Cardiology|August 17, 2013
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patientsAlessandro Lupi, Andrea Rognoni, Gioel Gabrio Secco, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 24, 2013
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacementFabrizio D'Ascenzo, Flavia Ballocca, Claudio Moretti, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Journal of the American College of Cardiology|June 7, 2008
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) RegistryEmanuele Meliga, Hector Manuel Garcia-Garcia, Marco Valgimigli, et al.
The Journal of Invasive Cardiology|July 12, 2012
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stentsMichael S Lee, Kyung Woo Park, Si-Hyuck Kang, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 27, 2014
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methodsClaudio Moretti, Erika Cavallero, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology|August 26, 2011
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)Marco Valgimigli, Gianluca Campo, Stefania Gambetti, et al.
Pageof 22